Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80,437,135
-
Number of holders
-
150
-
Total 13F shares, excl. options
-
32,590,375
-
Shares change
-
+71,074
-
Total reported value, excl. options
-
$869,951,071
-
Value change
-
-$27,487,489
-
Put/Call ratio
-
76%
-
Number of buys
-
94
-
Number of sells
-
75
-
Price
-
$26.70
Institutional Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q3 2015
As of 30 Sep 2015 PTC THERAPEUTICS, INC. - Common Stock (PTCT) had 230 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 32,590,375 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, WELLS FARGO & COMPANY/MN, WADDELL & REED FINANCIAL INC, FMR LLC, BlackRock Fund Advisors, BB BIOTECH AG, WESTFIELD CAPITAL MANAGEMENT CO LP, STATE STREET CORP, and ALLIANCEBERNSTEIN L.P..
This table shows 230 institutional shareholders of the security as of 30 Sep 2015.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.